Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: April 1, 2023

Drug Sales Trends for TOPIRAMATE

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

Payment Methods and Pharmacy Types for TOPIRAMATE (2019)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$58,945,717
INSIDE ANOTHER STORE	$220,562,894
[disabled in preview]	$1,031,895,459
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	643,242
INSIDE ANOTHER STORE	2,436,078
[disabled in preview]	7,428,174
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$502,244,798
MEDICARE	$134,263,447
[disabled in preview]	$674,895,823
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for TOPIRAMATE

Drug Units Sold Trends for TOPIRAMATE

Annual Sales Revenues and Units Sold for TOPIRAMATE

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Sign Up
Drug Name	Revenues (USD)	Units	Year
TOPIRAMATE	⤷ Sign Up	⤷ Sign Up	2019
TOPIRAMATE	⤷ Sign Up	⤷ Sign Up	2018
TOPIRAMATE	⤷ Sign Up	⤷ Sign Up	2017
TOPIRAMATE	⤷ Sign Up	⤷ Sign Up	2016
TOPIRAMATE	⤷ Sign Up	⤷ Sign Up	2015
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Moodys

AstraZeneca

Baxter

Boehringer Ingelheim

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.